Related to AVI BioPharma Obtains Expanded DoD Contract Worth $11.5M for Its Junin Virus Infection Treatment

• Fraunhofer Center Wins Up to $9.9M for Next-Gen Anthrax Vaccines
  
• Congress Clears Way for Obama Signature on PAHPRA
  
• Bioethics Panel Urges Caution in Testing MCMs on Children
  
• VaxInnate Wins $2.2M NIAID Grant for Dengue Vaccine
  
• Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device
  
• Soligenix, Intrexon Team Up on Dual-Purpose Drug Discovery Initiative
  
• Achaogen Scores $26.6M Five-Year Contract Covering Biothreat Bacterial Strains
  
• Northeast Biodefense Center Pockets $46M from the NIAID
  
• SIGA Wins $2.8M DoD Contract to Progress Antiviral into the Clinic
  
• Synedgen Wins $2.73M U.S. Army Grant to Combat Drug-Resistant Bacteria
  
• Trius Wins $29.5M Contract to Develop Antibiotics for Gram-Negative Pathogens
  
• Pulmatrix Gets $5.7M DARPA Funding To Develop Host-Targeted Inhaled Therapies
  
• DoD Pledges $4.6M to Establish Infection Genomics Center at UTSA
  
• GSK Awarded $38.5M Contract to Develop Antibiotic for Biodefense and Drug-Resistant Infections
  
• CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program
  
• LaserGen Wins Grant for Next-Gen Sequencing Test for Wound Infection Pathogens
  
• Accelr8, Denver Health Win $2M to Develop Battlefield Infections Diagnostic
  
• A Blow Against Biowarfare: Elusys Awarded $50.2M More for Inhalational Anthrax Treatment
  
• Biothreat Detection in the Palm of Your Hand
  
• Diagnostics Platform Coming to Your Smartphone